AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

XTL Biopharmaceuticals Ltd.

Regulatory Filings Aug 1, 2006

7116_rns_2006-08-01_25373d38-e8c3-43bc-a90d-9c1ccaac6978.htm

Regulatory Filings

Open in Viewer

Opens in native device viewer

_________

C004��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: ��� �� ��1996352Hasapir 3 , Nes Ziona 76100 , ,Tel: 08-9304444 , Fax: 08-9304445E.mail address: [email protected] of transmission: 01/08/2006              Time of broadcast: 10:02 10:00:59

Reference: 2006-02-066532

Israel Securities Authority Tel Aviv Stock Exchange
www.isa.gov.il www.tase.co.il

Immediate report on other matterDon't use this form if there is more adequate one

����� ������ �� ������ �� �'���� ���������, ������� �����
Attached file JSpicehandler_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 04/06/2006
- - -
Name of the Signatory: : Kantor Ronen , , Position of Signatory in the reporting corporation: Legal Consultant & Corporate Secretary
Abba Hillel Silver Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.